3-((3R,4R)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Amino)Piperidin-1-Yl)-3-Oxopropanamide
98%
- Product Code: 231545
CAS:
1675248-19-7
| Molecular Weight: | 330.39 g./mol | Molecular Formula: | C₁₆H₂₂N₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature |
Product Description:
Used as a potent inhibitor in targeted cancer therapies, particularly in the treatment of certain hematologic malignancies. It functions by selectively inhibiting specific kinase enzymes involved in signaling pathways that drive tumor cell proliferation and survival. Its application is prominent in the development of oral therapeutics for chronic myeloid leukemia (CML) and other myeloproliferative disorders. Due to its high selectivity and favorable pharmacokinetic profile, it enables sustained target suppression with reduced off-target effects, making it suitable for long-term treatment regimens. It is also investigated for use in resistant or relapsed cases where conventional therapies fail, offering a valuable option in precision oncology.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿140,170.00 |
+
-
|
3-((3R,4R)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Amino)Piperidin-1-Yl)-3-Oxopropanamide
Used as a potent inhibitor in targeted cancer therapies, particularly in the treatment of certain hematologic malignancies. It functions by selectively inhibiting specific kinase enzymes involved in signaling pathways that drive tumor cell proliferation and survival. Its application is prominent in the development of oral therapeutics for chronic myeloid leukemia (CML) and other myeloproliferative disorders. Due to its high selectivity and favorable pharmacokinetic profile, it enables sustained target suppression with reduced off-target effects, making it suitable for long-term treatment regimens. It is also investigated for use in resistant or relapsed cases where conventional therapies fail, offering a valuable option in precision oncology.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :